Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial

BACKGROUND: In the severe forms of COVID-19 and many other infectious diseases, the patients develop a cytokine storm syndrome (CSS) where pro-inflammatory cytokines such as IL-6 and TNF-α play a key role in the development of this serious process. Selenium and iron are two important trace minerals,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafizi, Maryam, Kalanaky, Somayeh, Fakharzadeh, Saideh, Karimi, Pegah, Fakharian, Atefeh, Lookzadeh, Somayeh, Mortaz, Esmaeil, Mirenayat, Maryam Sadat, Heshmatnia, Jalal, Karam, Mehrdad Bakhshayesh, Zamani, Homa, Nadji, Alireza, Toutkaboni, Mihan Pourabdollah, Oraee-Yazdani, Saeed, Akbari, Mohammad Esmaeil, Jamaati, Hamidreza, Nazaran, Mohammad Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638761/
https://www.ncbi.nlm.nih.gov/pubmed/37951972
http://dx.doi.org/10.1186/s13063-023-07624-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638761/
https://www.ncbi.nlm.nih.gov/pubmed/37951972
http://dx.doi.org/10.1186/s13063-023-07624-2

Ejemplares similares